Table 2g. Methylation patterns of CpG sites on matrix metallo proteinase between Kawasaki disease patients and control subjects.
Target ID | Symbol | Fold-Change | p-value | Fold-Change | p-value | Fold-Change | p-value |
---|---|---|---|---|---|---|---|
(KD1 vs. HC) | (KD1 vs. HC) | (KD1 vs. FC) | (KD1 vs. FC) | (KD3 vs. KD1) | (KD3 vs. KD1) | ||
cg19612376 | MMP25 | -1.004 | 0.237 | 1.001 | 0.789 | -1.003 | 0.295 |
cg22053861 | -1.004 | 0.061 | -1.002 | 0.255 | -1.001 | 0.490 | |
cg23531828 | 1.002 | 0.867 | -1.012 | 0.181 | -1.014 | 0.125 | |
cg25584355 | 1.001 | 0.585 | -1.005 | 0.008* | 1.001 | 0.496 | |
cg26705553 | -1.006 | 0.001* | 1.009 | 0.000* | -1.003 | 0.172 | |
cg26942943 | -1.006 | 0.006* | -1.002 | 0.444 | 1.010 | 0.000* | |
cg02706104 | MMP26 | -1.005 | 0.147 | 1.000 | 0.990 | -1.038 | 0.000* |
cg05316601 | -1.013 | 0.000* | -1.003 | 0.334 | -1.030 | 0.000* | |
cg09805271 | -1.013 | 0.176 | -1.009 | 0.335 | -1.104 | 0.000* | |
cg12493906 | -1.028 | 0.000* | -1.008 | 0.143 | 1.017 | 0.002* | |
cg17992177 | -1.018 | 0.001* | -1.006 | 0.261 | -1.032 | 0.000* | |
cg23389785 | -1.009 | 0.015* | -1.006 | 0.108 | 1.000 | 0.943 | |
cg06259570 | MMP27 | -1.012 | 0.012* | -1.011 | 0.019* | -1.037 | 0.000* |
cg09758894 | -1.011 | 0.015* | 1.008 | 0.082 | -1.015 | 0.001* | |
cg13252516 | 1.003 | 0.329 | 1.006 | 0.080 | -1.038 | 0.000* | |
cg18932968 | -1.003 | 0.302 | 1.013 | 0.000* | -1.025 | 0.000* | |
cg25277638 | -1.024 | 0.039* | -1.009 | 0.456 | 1.004 | 0.730 | |
cg01134296 | MMP28 | -1.024 | 0.000* | -1.019 | 0.000* | 1.020 | 0.000* |
cg01352921 | -1.001 | 0.304 | -1.002 | 0.201 | 1.004 | 0.001* | |
cg01622018 | -1.062 | 0.000* | -1.022 | 0.046* | 1.018 | 0.091 | |
cg04790749 | -1.004 | 0.614 | 1.009 | 0.273 | -1.063 | 0.000* | |
cg07330075 | -1.005 | 0.184 | 1.009 | 0.021* | -1.029 | 0.000* | |
cg07546558 | 1.009 | 0.002* | 1.008 | 0.003* | -1.011 | 0.000* | |
cg07916589 | -1.005 | 0.231 | 1.006 | 0.164 | 1.004 | 0.378 | |
cg09357580 | 1.004 | 0.004* | 1.003 | 0.031* | -1.003 | 0.018* | |
cg09730211 | 1.003 | 0.143 | 1.007 | 0.003* | -1.014 | 0.000* | |
cg09807148 | -1.014 | 0.000* | -1.002 | 0.444 | -1.002 | 0.501 | |
cg12700449 | -1.028 | 0.000* | -1.017 | 0.001* | -1.001 | 0.893 | |
cg13326172 | 1.001 | 0.460 | -1.005 | 0.001* | 1.005 | 0.001* | |
cg16246294 | 1.002 | 0.486 | 1.014 | 0.000* | -1.015 | 0.000* | |
cg25172682 | 1.018 | 0.095 | 1.009 | 0.415 | -1.042 | 0.000* |
For simplicity, we listed the p values only to 10-3. Actually, the CpG marker cg10505873 (the target for further examination) has p value < 10-5 among all of the three comparisons (KD1 vs. FC, KD1 vs. HC and KD3 vs. KD1). When examined with the FDR (with Bonferroni correction), cg10505873 is also significant among the three comparisons.
KD1: Kawasaki disease before IVIG treatment; KD3: Kawasaki disease > 3 weeks after IVIG treatment; FC: febrile control; HC: healthy control.